About Opiant Pharmaceuticals (NASDAQ:OPNT)

Opiant Pharmaceuticals, Inc., formerly Lightlake Therapeutics, Inc., is a specialty pharmaceutical company. The Company develops pharmacological treatments for substance use, addictive and eating disorders. The Company has developed NARCAN (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdoses, which was conceived, licensed, developed and approved by the United States Food and Drug Administration (FDA). The Company's pipeline of product candidates includes a treatment for Binge Eating Disorder (BED), a treatment for Bulimia Nervosa (BN), a treatment for Cocaine Use Disorder (CocUD) and a heroin vaccine. The Company also is focused on other treatment opportunities.

Receive OPNT News and Ratings via Email

Sign-up to receive the latest news and ratings for OPNT and its competitors with MarketBeat's FREE daily newsletter.

Profitability

Miscellaneous

Opiant Pharmaceuticals (NASDAQ:OPNT) Frequently Asked Questions

What is Opiant Pharmaceuticals' stock symbol?

Opiant Pharmaceuticals trades on the NASDAQ under the ticker symbol "OPNT."

How were Opiant Pharmaceuticals' earnings last quarter?

Opiant Pharmaceuticals Inc (NASDAQ:OPNT) released its quarterly earnings data on Monday, December, 4th. The technology company reported ($2.77) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($1.19) by $1.58. The technology company had revenue of $0.02 million for the quarter. Opiant Pharmaceuticals had a net margin of 8.93% and a return on equity of 42.44%. View Opiant Pharmaceuticals' Earnings History.

Opiant Pharmaceuticals' stock was purchased by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC and Spark Investment Management LLC. Company insiders that have bought Opiant Pharmaceuticals stock in the last two years include Kevin Pollack, Michael Sinclair and Roger Crystal. View Insider Buying and Selling for Opiant Pharmaceuticals.

How do I buy Opiant Pharmaceuticals stock?

Shares of Opiant Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Opiant Pharmaceuticals' stock price today?

One share of Opiant Pharmaceuticals stock can currently be purchased for approximately $22.72.

How big of a company is Opiant Pharmaceuticals?

Opiant Pharmaceuticals has a market capitalization of $52.50 million and generates $18.45 million in revenue each year. The technology company earns $6.58 million in net income (profit) each year or $0.42 on an earnings per share basis. Opiant Pharmaceuticals employs 11 workers across the globe.

MarketBeat Community Rating for Opiant Pharmaceuticals (OPNT)

MarketBeat's community ratings are surveys of what our community members think about Opiant Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.